Tag: FDA bioequivalence
Medical Society Guidelines: Official Positions on Generic Drug Use
Explore how medical societies like the AAN and AMA shape generic drug policies. Learn why some specialties oppose substitution for safety reasons while others embrace cost savings.
Batch Variability and Bioequivalence: What Acceptable Limits Really Mean for Generic Drugs
Explains how batch variability affects generic drug approval, why current bioequivalence limits may be flawed, and how new methods like Between-Batch Bioequivalence are improving safety and accuracy.